Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Skin Cancer, Liver Cancer, Cancer, Gastrointestinal, Pancreatic Cancer |
| Therapuetic Areas: | Gastroenterology, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/14/2018 |
| Start Date: | March 2000 |
| End Date: | December 2019 |
Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites.
Doctors at Memorial Sloan Kettering Cancer Center and at other institutions study normal and
cancer cells. To study these cells we need to have human tissue, body fluids, and blood. The
patient will be having or have had a procedure to remove tissue. The doctors would like to
use some of this tissue. The doctors will use it for laboratory studies on the causes,
prevention, diagnosis and treatment of sarcoma, gastrointestinal or other intra-abdominal
cancers. They will only use extra tissue left over after all needed testing has been done.
They would also like to study components of the immune blood cells and blood serum (the
liquid portion of the blood). In some patients they will take a blood sample before the
tissue or body fluid is removed, usually at the same time that other routine pre-procedure
blood tests are drawn. If thet need more blood, it will be drawn when the patient is seeing
the doctor anyway. We will not draw more than 50cc (4-5 tablespoons) at any one time. With
the patient's permission, thet may also send a small portion of the blood and/or a sample of
the tissue to a repository at the National Cancer Institute. This will be used to identify
special proteins in the blood or tissue that may be useful for diagnosing cancer. Information
about the treatment and the response to treatment may be linked to the tissue specimens
obtained. This information may be important for the research studies that will be done on the
tissue, body fluid and blood specimens. All of this information will be kept in strictest
confidence; they will use it only for biomedical research. The patient's name will not be
used in any report.
cancer cells. To study these cells we need to have human tissue, body fluids, and blood. The
patient will be having or have had a procedure to remove tissue. The doctors would like to
use some of this tissue. The doctors will use it for laboratory studies on the causes,
prevention, diagnosis and treatment of sarcoma, gastrointestinal or other intra-abdominal
cancers. They will only use extra tissue left over after all needed testing has been done.
They would also like to study components of the immune blood cells and blood serum (the
liquid portion of the blood). In some patients they will take a blood sample before the
tissue or body fluid is removed, usually at the same time that other routine pre-procedure
blood tests are drawn. If thet need more blood, it will be drawn when the patient is seeing
the doctor anyway. We will not draw more than 50cc (4-5 tablespoons) at any one time. With
the patient's permission, thet may also send a small portion of the blood and/or a sample of
the tissue to a repository at the National Cancer Institute. This will be used to identify
special proteins in the blood or tissue that may be useful for diagnosing cancer. Information
about the treatment and the response to treatment may be linked to the tissue specimens
obtained. This information may be important for the research studies that will be done on the
tissue, body fluid and blood specimens. All of this information will be kept in strictest
confidence; they will use it only for biomedical research. The patient's name will not be
used in any report.
Inclusion Criteria:
For patients:
- All patients with benign or malignant tumors of the soft tissues, gastrointestinal
tract, and other intra-abdominal sites who will have or have had tissue, peritoneal,
pleural, cyst, urine, and/or other gastrointestinal fluid removed for therapeutic or
diagnostic purposes.
- Patients will be entered without preference for any particular racial/ethnic group.
- Patients may have received prior hormonal therapy, cytotoxic chemotherapy,
irradiation, immunotherapy or surgical therapy.
- Tissue and body fluid specimens must be a large enough quantity to allow routine
pathological analysis, with the research laboratory specimen removed from the residual
specimen which would otherwise be discarded.
Healthy Control Subjects:
- Any male or female with no concurrent malignancies (except for localized basal cell or
squamous cell skin cancer) within 5 years of enrollment.
- > or = to 18 years of age
- Any MSKCC employee will be allowed to participate as a healthy control, provided they
fulfill the above inclusion criteria and they enroll willfully and voluntarily
Exclusion Criteria:
Healthy Control Subjects:
- Attending physicians authorized to obtain informed consent may exercise discretion in
excluding individuals for appropriate medical or other (e.g. mentally impaired)
reasons.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
